SCHEMBL18800769

SCHEMBL18800769

COc1cccc(-c2ncc(-c3ccc(Oc4ccccc4)cc3)c(C(=N)N)c2N)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.48
▸ ADORA1 P30542 2/20 0.48
▸ TNK2 Q07912 1/20 0.47
▸ BTK Q06187 8/20 0.45
▸ FYN P06241 1/20 0.44
▸ CHEK2 O96017 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ STAT1 P42224 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ ADORA2B P29275 1/20 0.42
▸ TSHR P16473 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ NCOA1 Q15788 2/20 0.40
▸ NCOA3 Q9Y6Q9 2/20 0.40
▸ TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800747 0.91 KMT2A (0.46) ADORA2AADORA1TNK2BTKNPC1
SCHEMBL18800661 0.89 ADORA1 (0.47) ADORA1TNK2BTKFYNCHEK2
SCHEMBL18800492 0.89 BTK (0.48) ADORA2AADORA1TNK2BTK
SCHEMBL18800775 0.88 TNK2 (0.48) ADORA2AADORA1TNK2BTKADORA2B
SCHEMBL18800616 0.88 BTK (0.47) ADORA2AADORA1TNK2BTK
SCHEMBL18800753 0.88 BTK (0.49) ADORA2AADORA1TNK2BTK
SCHEMBL18800469 0.87 BTK (0.61) TNK2BTKMAPK10
SCHEMBL18800748 0.87 BTK (0.42) TNK2BTKFYNNPC1RAB9A
SCHEMBL18800749 0.87 TNK2 (0.49) TNK2BTKFYNCHEK2
SCHEMBL18800463 0.87 BTK (0.60) ADORA2AADORA1TNK2BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback